Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Renal Microvessel Imaging for Chronic Kidney Disease
Sponsor: Mayo Clinic
Summary
The purpose of this research is to study the efficacy of ultrasound microvessel imaging for evaluation of Chronic Kidney Disease. Definity is an ultrasound contrast agent currently approved by the FDA for use on the heart, liver, and urinary tract. This study will look at its effectiveness on the kidney.
Official title: Renal Microvessel Imaging for Characterization of Chronic Kidney Disease
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
186
Start Date
2023-08-09
Completion Date
2028-04
Last Updated
2025-09-05
Healthy Volunteers
Yes
Conditions
Interventions
Definity
Ultrasound contrast agent administered intravenously
Super-resolution ultrasound imaging
Imaging technology for microvessel imaging. This technology localizes and tracks individual microbubbles (FDA approved ultrasound contrast agents) to map microvessel morphology and flow speed at a spatial resolution about 10 times higher than conventional ultrasound imaging.
Locations (2)
Mayo Clinic Florida
Jacksonville, Florida, United States
Mayo Clinic Minnesota
Rochester, Minnesota, United States